British Patient Capital has announced a £70.2m ($90m) commitment to Balderton Capital’s latest funds, investing around £19.5m ($25m) into Balderton IX and £50.7m ($65m) into Balderton Growth II. The funds have raised a combined $1.3bn to back Europe’s most ambitious entrepreneurs from seed stage through to IPO. Since its founding in 2000, Balderton has invested … Continue reading British Patient Capital pledges £70m to Balderton funds